BACKGROUND: Many patients do not maintain physical activity levels after completion of phase III exercise-based cardiac rehabilitation. DESIGN: This study determined the effect of an exercise consultation on maintenance of physical activity and cardiorespiratory fitness 12 months after completion of a phase III exercise programme. Seventy cardiac patients were randomized to the experimental (exercise consultation and exercise information) or control groups (exercise information only). METHODS: Outcomes recorded at baseline, 6 and 12 months were: physical activity (stage of change, 7-day recall, accelerometer), cardiorespiratory fitness, lipids, quality of life, anxiety and depression. RESULTS: Both groups were regularly active at baseline. The between-group difference for the change in total activity (min/week) assessed by the 7-day recall was significant from baseline to 12 months [98% confidence interval (CI) -295, -20]. Total activity was maintained in the experimental group (98% CI -63, 154) and significantly decreased in the control group (115 min/week; 98% CI -228, -28) from baseline to 12 months. The between-group difference for the change in accelerometer counts/week was not significant from baseline to 6 (98% CI -1 143 720, 607 430) or 12 months (98% CI -1 131 128, 366 473). A comparable, significant decrease in peak oxygen uptake occurred from baseline to 12 months in experimental (1.8 ml/kg per min; 98% CI -3.2, -0.3) and control participants (2.3 ml/kg per min; -3.8, -0.8). Lipids, quality of life, anxiety and depression were normal at baseline and did not significantly change in either group over time. CONCLUSION:Exercise consultation was effective in maintaining self-reported physical activity, but not peak oxygen uptake, for 12 months after completion of phase III.
RCT Entities:
BACKGROUND: Many patients do not maintain physical activity levels after completion of phase III exercise-based cardiac rehabilitation. DESIGN: This study determined the effect of an exercise consultation on maintenance of physical activity and cardiorespiratory fitness 12 months after completion of a phase III exercise programme. Seventy cardiac patients were randomized to the experimental (exercise consultation and exercise information) or control groups (exercise information only). METHODS: Outcomes recorded at baseline, 6 and 12 months were: physical activity (stage of change, 7-day recall, accelerometer), cardiorespiratory fitness, lipids, quality of life, anxiety and depression. RESULTS: Both groups were regularly active at baseline. The between-group difference for the change in total activity (min/week) assessed by the 7-day recall was significant from baseline to 12 months [98% confidence interval (CI) -295, -20]. Total activity was maintained in the experimental group (98% CI -63, 154) and significantly decreased in the control group (115 min/week; 98% CI -228, -28) from baseline to 12 months. The between-group difference for the change in accelerometer counts/week was not significant from baseline to 6 (98% CI -1 143 720, 607 430) or 12 months (98% CI -1 131 128, 366 473). A comparable, significant decrease in peak oxygen uptake occurred from baseline to 12 months in experimental (1.8 ml/kg per min; 98% CI -3.2, -0.3) and control participants (2.3 ml/kg per min; -3.8, -0.8). Lipids, quality of life, anxiety and depression were normal at baseline and did not significantly change in either group over time. CONCLUSION: Exercise consultation was effective in maintaining self-reported physical activity, but not peak oxygen uptake, for 12 months after completion of phase III.
Authors: Sabine Stamm-Balderjahn; Martin Brünger; Anne Michel; Christa Bongarth; Karla Spyra Journal: Dtsch Arztebl Int Date: 2016-08-08 Impact factor: 5.594
Authors: Bernardine M Pinto; Michael G Goldstein; George D Papandonatos; Nancy Farrell; Peter Tilkemeier; Bess H Marcus; John F Todaro Journal: Am J Prev Med Date: 2011-09 Impact factor: 5.043
Authors: Bernice C Yates; Joseph Norman; Jane Meza; Kaye Stanek Krogstrand; Susana Harrington; Scott Shurmur; Matthew Johnson; Karen Schumacher Journal: J Cardiovasc Nurs Date: 2015 Mar-Apr Impact factor: 2.083
Authors: Peter C Rouse; Jet J C S Veldhuijzen Van Zanten; George S Metsios; Nikos Ntoumanis; Chen-an Yu; Yiannis Koutedakis; Sally A M Fenton; Joanna Coast; Hema Mistry; George D Kitas; Joan L Duda Journal: BMC Musculoskelet Disord Date: 2014-12-19 Impact factor: 2.362
Authors: Claire F Fitzsimons; Graham Baker; Annemarie Wright; Myra A Nimmo; Catharine Ward Thompson; Ruth Lowry; Catherine Millington; Rebecca Shaw; Elisabeth Fenwick; David Ogilvie; Joanna Inchley; Charlie E Foster; Nanette Mutrie Journal: BMC Public Health Date: 2008-07-26 Impact factor: 3.295